Head and Neck Cancer Market Size, Share, Trends, Industry Analysis Report: By Therapy Type, Route of Administration, Distribution Channel, and Region

Description

List of Tables

The head and neck cancer market size is expected to reach USD 7,684.82 Million by 2034, according to a new study by Polaris Market Research. The report "Head and Neck Cancer Market Size, Share, Trends, Industry Analysis Report: By Therapy Type (Chemotherapy, Immunotherapy, and Targeted Therapy), Route of Administration, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Head and Neck Cancer Market includes treatments, diagnostics, and therapies for malignancies in the mouth, throat, larynx, and related regions, driven by rising incidence, advanced therapies, and increasing healthcare investments.

The head and neck cancer market growth are driven by several factors, including the increasing prevalence of risk factors such as smoking, alcohol use, and HPV infections, which contribute to a rising number of cancer cases globally. Advances in treatment options, particularly immunotherapies such as immune checkpoint inhibitors, and targeted therapies, are offering new hope for patients, driving market growth. Additionally, the growing emphasis on personalized medicine, early detection methods, and minimally invasive surgical techniques are shaping the landscape of the market. Head and neck cancer market opportunities exist in expanding access to innovative therapies in emerging markets, where the incidence of head and neck cancer is rising.

Trends such as the shift toward combination therapies, oral treatment options, and digital health tools are further enhancing the treatment experience. The overall head and neck cancer market expansion is supported by ongoing research, clinical trials, and collaborations aimed at improving treatment outcomes and patient quality of life.

Head and Neck Cancer Market Report Highlights:

Based on therapy type, the chemotherapy segment dominates the head and neck cancer market share. It is used for particularly advanced stages. However, immunotherapy is the fastest-growing segment due to the increasing adoption of immune checkpoint inhibitors such as nivolumab and pembrolizumab.

By route of administration, the injectable segment, especially immunotherapies and chemotherapy, holds a larger market share due to their widespread use in cancer treatment, while the oral segment is growing rapidly as patient preference shifts toward more convenient treatment options.

The hospital pharmacies segment, by distribution channel, dominates the market as they are critical for the administration of complex treatments. However, the online pharmacy segment is experiencing the highest growth, driven by increasing e-commerce adoption and home delivery services for oral cancer drugs.

North America holds the largest share of the global head and neck cancer market revenue due to its advanced healthcare infrastructure and high adoption of new therapies. On the other hand, Asia Pacific is the highest-growing region, driven by rising cancer incidence, improving healthcare access, and increasing demand for innovative treatment options.

Polaris Market Research has segmented the head and neck cancer market report on the basis of therapy type, route of administration, distribution channel, and region:

By Therapy Type Outlook (Revenue - USD Million, 2020-2034)

Chemotherapy
Immunotherapy
Targeted Therapy

By Route of Administration Outlook (Revenue - USD Million, 2020-2034)

Injectable
Oral

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

Retail & Specialty Pharmacies
Hospital Pharmacies
Online Pharmacies

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM1330

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Head and Neck Cancer Market Insights

4.1. Head and Neck Cancer Market - Market Snapshot
4.2. Head and Neck Cancer Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Focus on Immunotherapy for Treatment
  - 4.2.1.2. Advancements in Early Detection and Diagnostic Tools
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Treatments
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Head and Neck Cancer Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Head and Neck Cancer Market, by Therapy Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
5.3. Chemotherapy
- 5.3.1. Global Head and Neck Cancer Market, by Chemotherapy, by Region, 2020-2034 (USD Million)
5.4. Immunotherapy
- 5.4.1. Global Head and Neck Cancer Market, by Immunotherapy, by Region, 2020-2034 (USD Million)
5.5. Targeted Therapy
- 5.5.1. Global Head and Neck Cancer Market, by Targeted Therapy, by Region, 2020-2034 (USD Million)

6. Global Head and Neck Cancer Market, by Route of Administration

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
6.3. Injectable
- 6.3.1. Global Head and Neck Cancer Market, by Injectable, by Region, 2020-2034 (USD Million)
6.4. Oral
- 6.4.1. Global Head and Neck Cancer Market, by Oral, by Region, 2020-2034 (USD Million)

7. Global Head and Neck Cancer Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
7.3. Retail & Specialty Pharmacies
- 7.3.1. Global Head and Neck Cancer Market, by Retail & Specialty Pharmacies, by Region, 2020-2034 (USD Million)
7.4. Hospital Pharmacies
- 7.4.1. Global Head and Neck Cancer Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Million)
7.5. Online Pharmacies
- 7.5.1. Global Head and Neck Cancer Market, by Online Pharmacies, by Region, 2020-2034 (USD Million)

8. Global Head and Neck Cancer Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Head and Neck Cancer Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Head and Neck Cancer Market - North America
- 8.3.1. North America: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
- 8.3.2. North America: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
- 8.3.3. North America: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3.4. Head and Neck Cancer Market - U.S.
  - 8.3.4.1. U.S.: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.3.4.2. U.S.: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.3.4.3. U.S.: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3.5. Head and Neck Cancer Market - Canada
  - 8.3.5.1. Canada: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
8.4. Head and Neck Cancer Market - Europe
- 8.4.1. Europe: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
- 8.4.2. Europe: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
- 8.4.3. Europe: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.4. Head and Neck Cancer Market - UK
  - 8.4.4.1. UK: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.5. Head and Neck Cancer Market - France
  - 8.4.5.1. France: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.4.5.2. France: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.5.3. France: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.6. Head and Neck Cancer Market - Germany
  - 8.4.6.1. Germany: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.7. Head and Neck Cancer Market - Italy
  - 8.4.7.1. Italy: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.8. Head and Neck Cancer Market - Spain
  - 8.4.8.1. Spain: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.9. Head and Neck Cancer Market - Netherlands
  - 8.4.9.1. Netherlands: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.10. Head and Neck Cancer Market - Russia
  - 8.4.10.1. Russia: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.11. Head and Neck Cancer Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
8.5. Head and Neck Cancer Market - Asia Pacific
- 8.5.1. Asia Pacific: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.4. Head and Neck Cancer Market - China
  - 8.5.4.1. China: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.5.4.2. China: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.4.3. China: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.5. Head and Neck Cancer Market - India
  - 8.5.5.1. India: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.5.5.2. India: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.5.3. India: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.6. Head and Neck Cancer Market - Malaysia
  - 8.5.6.1. Malaysia: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.7. Head and Neck Cancer Market - Japan
  - 8.5.7.1. Japan: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.8. Head and Neck Cancer Market - Indonesia
  - 8.5.8.1. Indonesia: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.9. Head and Neck Cancer Market - South Korea
  - 8.5.9.1. South Korea: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.10. Head and Neck Cancer Market - Australia
  - 8.5.10.1. Australia: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.11. Head and Neck Cancer Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
8.6. Head and Neck Cancer Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.4. Head and Neck Cancer Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.5. Head and Neck Cancer Market - UAE
  - 8.6.5.1. UAE: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.6. Head and Neck Cancer Market - Israel
  - 8.6.6.1. Israel: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.7. Head and Neck Cancer Market - South Africa
  - 8.6.7.1. South Africa: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.8. Head and Neck Cancer Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
8.7. Head and Neck Cancer Market - Latin America
- 8.7.1. Latin America: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
- 8.7.2. Latin America: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
- 8.7.3. Latin America: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.4. Head and Neck Cancer Market - Mexico
  - 8.7.4.1. Mexico: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.5. Head and Neck Cancer Market - Brazil
  - 8.7.5.1. Brazil: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.6. Head and Neck Cancer Market - Argentina
  - 8.7.6.1. Argentina: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.7. Head and Neck Cancer Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Head and Neck Cancer Market, by Therapy Type, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Head and Neck Cancer Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Head and Neck Cancer Market, by Distribution Channel, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Bristol-Myers Squibb
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Merck & Co.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Eli Lilly
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Roche
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. AstraZeneca
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Novartis
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Pfizer
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Johnson & Johnson
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Sanofi
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Boehringer Ingelheim
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development